1,727
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury

, , , , , , , , & show all
Pages 1054-1064 | Received 21 Oct 2022, Accepted 21 May 2023, Published online: 07 Jul 2023

References

  • Ayazi M, Zivkovic S, Hammel G, Stefanovic B, Ren Y. 2022. Fibrotic scar in CNS injuries: from the cellular origins of fibroblasts to the molecular processes of fibrotic scar formation. Cells. 11(15):2371. doi: 10.3390/cells11152371.
  • Bai X, Wang WX, Fu RJ, Yue SJ, Gao H, Chen YY, Tang YP. 2020. Therapeutic potential of hydroxysafflor yellow A on cardio-cerebrovascular diseases. Front Pharmacol. 11:01265. doi: 10.3389/fphar.2020.01265.
  • Bie XD, Han J, Dai HB. 2010. Effects of hydroxysafflor yellow A on the experimental traumatic brain injury in rats. J Asian Nat Prod Res. 12(3):239–247. doi: 10.1080/10286020903510636.
  • Burda JE, Bernstein AM, Sofroniew MV. 2016. Astrocyte roles in traumatic brain injury. Exp Neurol. 275:305–315. doi: 10.1016/j.expneurol.2015.03.020.
  • Chen S, Sun M, Zhao X, Yang Z, Liu W, Cao J, Qiao Y, Luo X, Wen A. 2019. Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis. Mol Med Rep. 19:3009–3020.
  • Chen X, Wang N, Zhang T, Wang F, Wu C, Yang J. 2014. Neuroprotection by sildenafil: neuronal networks potentiation in acute experimental stroke. CNS Neurosci Ther. 20(1):40–49. doi: 10.1111/cns.12162.
  • Chinese Pharmacopoeia Commission. 2020. Chinese Pharmacopoeia. Beijing, China: Medical Science and Technology Press.
  • Fernandes CG, Leipnitz G, Seminotti B, Amaral AU, Zanatta A, Vargas CR, Dutra FC, Wajner M. 2010. Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats. Cell Mol Neurobiol. 30(2):317–326. doi: 10.1007/s10571-009-9455-6.
  • Fesharaki-Zadeh A. 2022. Oxidative stress in traumatic brain injury. Int J Mol Sci. 23(21):13000. doi: 10.3390/ijms232113000.
  • Gustafsson D, Klang A, Thams S, Rostami E. 2021. The role of BDNF in experimental and clinical traumatic brain injury. Int J Mol Sci. 22(7):3582. doi: 10.3390/ijms22073582.
  • Hall ED, Sullivan PG, Gibson TR, Pavel KM, Thompson BM, Scheff SW. 2005. Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J Neurotrauma. 22(2):252–265. doi: 10.1089/neu.2005.22.252.
  • Hartwig C, Gal A, Santer R, Ullrich K, Finckh U, Kreienkamp HJ. 2006. Elevated phenylalanine levels interfere with neurite outgrowth stimulated by the neuronal cell adhesion molecule L1 in vitro. FEBS Lett. 580(14):3489–3492. doi: 10.1016/j.febslet.2006.05.026.
  • He J, Huang Y, Liu H, Sun X, Wu J, Zhang Z, Liu L, Zhou C, Jiang S, Huang Z, et al. 2020. Bexarotene promotes microglia/macrophages-specific brain-derived neurotrophic factor expression and axon sprouting after traumatic brain injury. Exp Neurol. 334:113462. doi: 10.1016/j.expneurol.2020.113462.
  • Huebner EA, Strittmatter SM. 2009. Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ. 48:339–351.
  • Hung CC, Lin CH, Chang H, Wang CY, Lin SH, Hsu PC, Sun YY, Lin TN, Shie FS, Kao LS, et al. 2016. Astrocytic GAP43 induced by the TLR4/NF-kappaB/STAT3 axis attenuates astrogliosis-mediated microglial activation and neurotoxicity. J Neurosci. 36(6):2027–2043. doi: 10.1523/JNEUROSCI.3457-15.2016.
  • Jarrahi A, Braun M, Ahluwalia M, Gupta RV, Wilson M, Munie S, Ahluwalia P, Vender JR, Vale FL, Dhandapani KM, et al. 2020. Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions. Biomedicines. 8(10):389. doi: 10.3390/biomedicines8100389.
  • Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. 2008. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 48:653–683. doi: 10.1146/annurev.pharmtox.48.113006.094715.
  • Lee M, Zhao H, Liu X, Liu D, Chen J, Li Z, Chu S, Kou X, Liao S, Deng Y, et al. 2020. Protective effect of hydroxysafflor yellow A on nephropathy by attenuating oxidative stress and inhibiting apoptosis in induced type 2 diabetes in rat. Oxid Med Cell Longev. 2020:7805393.
  • Leibinger M, Andreadaki A, Diekmann H, Fischer D. 2013. Neuronal STAT3 activation is essential for CNTF – and inflammatory stimulation-induced CNS axon regeneration. Cell Death Dis. 4(9):e805. doi: 10.1038/cddis.2013.310.
  • Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA. 1989. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341(6238):149–152. doi: 10.1038/341149a0.
  • Li T, Hu E, Li P, Yang Z, Wu Y, Ding R, Zhu X, Tang T, Wang Y. 2020. Metabolomics deciphers potential targets of Xuefu Zhuyu decoction against traumatic brain injury in rat. Front Pharmacol. 11:559618. doi: 10.3389/fphar.2020.559618.
  • Li T, Zhang W, Hu E, Sun Z, Li P, Yu Z, Zhu X, Zheng F, Xing Z, Xia Z, et al. 2021. Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury. Comput Struct Biotechnol J. 19:1002–1013. doi: 10.1016/j.csbj.2021.01.033.
  • Liu Q, Wang CY, Liu Z, Ma XS, He YH, Chen SS, Bai XY. 2014. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-gamma/p38 MAPK signaling. Pharm Biol. 52(9):1085–1093. doi: 10.3109/13880209.2013.877491.
  • Mccrea MA, Giacino JT, Barber J, Temkin NR, Nelson LD, Levin HS, Dikmen S, Stein M, Bodien YG, Boase K, et al. 2021. Functional outcomes over the first year after moderate to severe traumatic brain injury in the prospective, longitudinal TRACK-TBI study. JAMA Neurol. 78(8):982–992. doi: 10.1001/jamaneurol.2021.2043.
  • Mehta ST, Luo X, Park KK, Bixby JL, Lemmon VP. 2016. Hyperactivated Stat3 boosts axon regeneration in the CNS. Exp Neurol. 280:115–120. doi: 10.1016/j.expneurol.2016.03.004.
  • Meyfroidt G, Bouzat P, Casaer MP, Chesnut R, Hamada SR, Helbok R, Hutchinson P, Maas AIR, Manley G, Menon DK, et al. 2022. Management of moderate to severe traumatic brain injury: an update for the intensivist. Intensive Care Med. 48(6):649–666. doi: 10.1007/s00134-022-06702-4.
  • Michinaga S, Koyama Y. 2021. Pathophysiological responses and roles of astrocytes in traumatic brain injury. Int J Mol Sci. 22(12):6418. doi: 10.3390/ijms22126418.
  • Nguyen L, He Q, Meiri KF. 2009. Regulation of GAP-43 at serine 41 acts as a switch to modulate both intrinsic and extrinsic behaviors of growing neurons via altered membrane distribution. Mol Cell Neurosci. 41(1):62–73. doi: 10.1016/j.mcn.2009.01.011.
  • Orr MB, Gensel JC. 2018. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics. 15(3):541–553. doi: 10.1007/s13311-018-0631-6.
  • Osier ND, Carlson SW, Desana A, Dixon CE. 2015. Chronic histopathological and behavioral outcomes of experimental traumatic brain injury in adult male animals. J Neurotrauma. 32(23):1861–1882. doi: 10.1089/neu.2014.3680.
  • Pan R, Zhang Y, Zheng M, Zang B, Jin M. 2017. Hydroxysafflor yellow A suppresses MRC-5 cell activation induced by TGF-β1 by blocking TGF-β1 binding to TβRII. Front Pharmacol. 8:264. doi: 10.3389/fphar.2017.00264.
  • Paxinos G, Watson C. 2007. The rat brain in stereotaxic coordinates. London: Academic Press.
  • Pei JP, Fan LH, Nan K, Li J, Dang XQ, Wang KZ. 2017. HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury. J Neuroinflammation. 14(1):97. doi: 10.1186/s12974-017-0870-1.
  • Preissler T, Bristot IJ, Costa BM, Fernandes EK, Rieger E, Bortoluzzi VT, de Franceschi ID, Dutra-Filho CS, Moreira JC, Wannmacher CM. 2016. Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria. Metab Brain Dis. 31(3):529–537. doi: 10.1007/s11011-015-9763-0.
  • Redell JB, Maynard ME, Underwood EL, Vita SM, Dash PK, Kobori N. 2020. Traumatic brain injury and hippocampal neurogenesis: functional implications. Exp Neurol. 331:113372. doi: 10.1016/j.expneurol.2020.113372.
  • Ribas VT, Vahsen BF, Tatenhorst L, Estrada V, Dambeck V, Almeida RA, Bahr M, Michel U, Koch JC, Muller HW, et al. 2021. AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo. Cell Death Dis. 12(2):213. doi: 10.1038/s41419-021-03503-3.
  • Rola R, Mizumatsu S, Otsuka S, Morhardt DR, Noble-Haeusslein LJ, Fishman K, Potts MB, Fike JR. 2006. Alterations in hippocampal neurogenesis following traumatic brain injury in mice. Exp Neurol. 202(1):189–199. doi: 10.1016/j.expneurol.2006.05.034.
  • Rubin R. 2020. Traumatic brain injury hospital stays are longer, more costly. JAMA. 323(20):1998. doi: 10.1001/jama.2020.8130.
  • Sheng C, Peng W, Xia Z, Wang Y. 2020. Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method. Xenobiotica. 50(5):545–551. doi: 10.1080/00498254.2019.1668983.
  • Shu X, Liu J, Jiang T, Li D, Li S, Li X. 2008. [Observational study on the distribution of traditional Chinese medicine syndrome after traumatic brain injury]. Chin Arch Trad Chin Med. 5:1051–1054.
  • Taniguchi E, Tashiro A, Hattori A, Furuse M, Yasuo S. 2021. Photoperiodic changes in hippocampal neurogenesis and plasma metabolomic profiles in relation to depression-like behavior in mice. Behav Brain Res. 403:113136. doi: 10.1016/j.bbr.2021.113136.
  • Tian Y, Yang ZF, Li Y, Qiao Y, Yang J, Jia YY, Wen AD. 2010. Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats. J Ethnopharmacol. 129(1):1–4. doi: 10.1016/j.jep.2010.02.023.
  • Wang Y, Zhang C, Peng W, Xia Z, Gan P, Huang W, Shi Y, Fan R. 2016. Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury. Mol Med Rep. 14(4):3690–3696. doi: 10.3892/mmr.2016.5720.
  • Wilson L, Stewart W, Dams-O’Connor K, Diaz-Arrastia R, Horton L, Menon DK, Polinder S. 2017. The chronic and evolving neurological consequences of traumatic brain injury. Lancet Neurol. 16(10):813–825. doi: 10.1016/S1474-4422(17)30279-X.
  • Xing M, Sun Q, Wang Y, Cheng Y, Zhang N. 2016. Hydroxysafflor yellow A increases BDNF and NMDARs in the hippocampus in a vascular dementia rat model. Brain Res. 1642:419–425. doi: 10.1016/j.brainres.2016.04.030.
  • Xiong Y, Mahmood A, Chopp M. 2013. Animal models of traumatic brain injury. Nat Rev Neurosci. 14(2):128–142. doi: 10.1038/nrn3407.
  • Xu J, Zhan T, Zheng W, Huang YK, Chen K, Zhang XH, Ren P, Huang X. 2021. Hydroxysafflor yellow A acutely attenuates blood-brain barrier permeability, oxidative stress, inflammation and apoptosis in traumatic brain injury in rats1. Acta Cir Bras. 35(12):e351202. doi: 10.1590/ACB351202.
  • Yu L, Duan Y, Zhao Z, He W, Xia M, Zhang Q, Cao X. 2018. Hydroxysafflor yellow A (HSYA) improves learning and memory in cerebral ischemia Reperfusion-Injured rats via recovering synaptic plasticity in the hippocampus. Front Cell Neurosci. 12:371. doi: 10.3389/fncel.2018.00371.
  • Zhang G, Bogdanova N, Gao T, Song JJ, Cragg MS, Glennie MJ, Sheikh KA. 2014. Fcγ receptor-mediated inflammation inhibits axon regeneration. PLoS One. 9(2):e88703. doi: 10.1371/journal.pone.0088703.
  • Zhang J, Jiang C, Liu X, Jiang CX, Cao Q, Yu B, Ni Y, Mao S. 2022. The metabolomic profiling identifies N, N-dimethylglycine as a facilitator of dorsal root ganglia neuron axon regeneration after injury. FASEB J. 36:e22305.
  • Zhang ZH, Yu LJ, Hui XC, Wu ZZ, Yin KL, Yang H, Xu Y. 2014. Hydroxy-safflor yellow A attenuates Aβ1_42-induced inflammation by modulating the JAK2/STAT3/NF-κb pathway. Brain Res. 1563:72–80. doi: 10.1016/j.brainres.2014.03.036.
  • Zheng F, Zhou Y, Li P, Hu E, Li T, Tang T, Luo J, Zhang W, Ding C, Wang Y. 2020. Metabolomics analysis of hippocampus and cortex in a rat model of traumatic brain injury in the subacute phase. Front Neurosci. 14:876. doi: 10.3389/fnins.2020.00876.
  • Zheng R, Lee K, Qi Z, Wang Z, Xu Z, Wu X, Mao Y. 2022. Neuroinflammation following traumatic brain injury: take it seriously or not. Front Immunol. 13:855701. doi: 10.3389/fimmu.2022.855701.